Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma.

BMC cancer

Volumn 8, Issue , 2008, Pages 34-

  Heimdal, John Helge ^a   Kross, Kenneth ^a   Klementsen, Beate ^a   Olofsson, Jan ^a   Aarstad, Hans Jørgen ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CCL2 PROTEIN, HUMAN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

AGED; ARTICLE; CELL CULTURE; FEMALE; HEAD AND NECK TUMOR; HUMAN; IMMUNOLOGY; MALE; MONOCYTE; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SECRETION; SQUAMOUS CELL CARCINOMA; SURVIVAL;

AGED; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; CHEMOKINE CCL2; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-6; MALE; MONOCYTES; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

MLCS; MLOWN;

EID: 41649121939     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-34     Document Type: Article

References (0)